These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
186 related items for PubMed ID: 16919599
1. Suppression of hypoxia inducible factor-1alpha (HIF-1alpha) by YC-1 is dependent on murine double minute 2 (Mdm2). Lau CK, Yang ZF, Lam CT, Tam KH, Poon RT, Fan ST. Biochem Biophys Res Commun; 2006 Oct 06; 348(4):1443-8. PubMed ID: 16919599 [Abstract] [Full Text] [Related]
3. Effects of YC-1 on hypoxia-inducible factor 1-driven transcription activity, cell proliferative vitality, and apoptosis in hypoxic human pancreatic cancer cells. Zhao Q, Du J, Gu H, Teng X, Zhang Q, Qin H, Liu N. Pancreas; 2007 Mar 06; 34(2):242-7. PubMed ID: 17312464 [Abstract] [Full Text] [Related]
4. YC-1 induces S cell cycle arrest and apoptosis by activating checkpoint kinases. Yeo EJ, Ryu JH, Chun YS, Cho YS, Jang IJ, Cho H, Kim J, Kim MS, Park JW. Cancer Res; 2006 Jun 15; 66(12):6345-52. PubMed ID: 16778212 [Abstract] [Full Text] [Related]
8. A domain responsible for HIF-1alpha degradation by YC-1, a novel anticancer agent. Kim HL, Yeo EJ, Chun YS, Park JW. Int J Oncol; 2006 Jul 15; 29(1):255-60. PubMed ID: 16773207 [Abstract] [Full Text] [Related]
9. YC-1 exerts inhibitory effects on MDA-MB-468 breast cancer cells by targeting EGFR in vitro and in vivo under normoxic condition. Cheng Y, Li W, Liu Y, Cheng HC, Ma J, Qiu L. Chin J Cancer; 2012 May 15; 31(5):248-56. PubMed ID: 22507221 [Abstract] [Full Text] [Related]
10. YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1. Yeo EJ, Chun YS, Cho YS, Kim J, Lee JC, Kim MS, Park JW. J Natl Cancer Inst; 2003 Apr 02; 95(7):516-25. PubMed ID: 12671019 [Abstract] [Full Text] [Related]
12. Hypoxia-induced overexpression of DEC1 is regulated by HIF-1α in hepatocellular carcinoma. Ma W, Shi X, Lu S, Wu L, Wang Y. Oncol Rep; 2013 Dec 02; 30(6):2957-62. PubMed ID: 24100543 [Abstract] [Full Text] [Related]
13. [Effects of hypoxia-inducible factor inhibitor on expression of HIF-1alpha and VEGF and induction of apoptosis in leukemic cell lines]. Wang F, Chen BA, Cheng J, Xu WL, Wang XM, Ding JH, Gao C, Sun YY, Wang J, Zhao G, Bao W, Song HH, Gao F, Zhang W, Xia GH, Pei XP, Wu WW, Yin L, Shan XY. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb 02; 18(1):74-8. PubMed ID: 20137122 [Abstract] [Full Text] [Related]
14. The effect of 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole (YC-1) on cell viability under hypoxia. Tsui L, Fong TH, Wang IJ. Mol Vis; 2013 Feb 02; 19():2260-73. PubMed ID: 24265542 [Abstract] [Full Text] [Related]
15. The effect of hypoxia-inducible factor 1-alpha on hypoxia-induced apoptosis in primary neonatal rat ventricular myocytes. Zhou YF, Zheng XW, Zhang GH, Zong ZH, Qi GX. Cardiovasc J Afr; 2010 Feb 02; 21(1):37-41. PubMed ID: 20224844 [Abstract] [Full Text] [Related]
17. Sorafenib inhibits hypoxia-inducible factor-1α synthesis: implications for antiangiogenic activity in hepatocellular carcinoma. Liu LP, Ho RL, Chen GG, Lai PB. Clin Cancer Res; 2012 Oct 15; 18(20):5662-71. PubMed ID: 22929805 [Abstract] [Full Text] [Related]
19. Modulating the hypoxia-inducible factor signaling pathway as a therapeutic modality to regulate retinal angiogenesis. DeNiro M, Alsmadi O, Al-Mohanna F. Exp Eye Res; 2009 Nov 15; 89(5):700-17. PubMed ID: 19580810 [Abstract] [Full Text] [Related]